Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1981 1
1985 1
1986 3
1987 4
1988 2
1989 4
1991 1
1992 1
1995 1
1996 1
1997 2
1998 1
1999 1
2000 1
2003 1
2005 6
2006 2
2007 1
2009 2
2011 1
2013 2
2014 3
2015 2
2016 2
2021 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.
International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group; Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK. International Collaboration of Trialists, et al. J Clin Oncol. 2011 Jun 1;29(16):2171-7. doi: 10.1200/JCO.2010.32.3139. Epub 2011 Apr 18. J Clin Oncol. 2011. PMID: 21502557 Free PMC article. Clinical Trial.
Proton beam radiotherapy.
Jones B, Errington RD. Jones B, et al. Among authors: errington rd. Br J Radiol. 2000 Aug;73(872):802-5. doi: 10.1259/bjr.73.872.11026853. Br J Radiol. 2000. PMID: 11026853 No abstract available.
Transpalpebral proton beam radiotherapy of choroidal melanoma.
Konstantinidis L, Roberts D, Errington RD, Kacperek A, Heimann H, Damato B. Konstantinidis L, et al. Among authors: errington rd. Br J Ophthalmol. 2015 Feb;99(2):232-5. doi: 10.1136/bjophthalmol-2014-305313. Epub 2014 Aug 19. Br J Ophthalmol. 2015. PMID: 25138766
Prognostic Biopsy of Choroidal Melanoma after Proton Beam Radiation Therapy.
Hussain RN, Kalirai H, Groenewald C, Kacperek A, Errington RD, Coupland SE, Heimann H, Damato B. Hussain RN, et al. Among authors: errington rd. Ophthalmology. 2016 Oct;123(10):2264-5. doi: 10.1016/j.ophtha.2016.05.028. Epub 2016 Jun 17. Ophthalmology. 2016. PMID: 27324683 No abstract available.
Proton beam radiotherapy of iris melanoma.
Damato B, Kacperek A, Chopra M, Sheen MA, Campbell IR, Errington RD. Damato B, et al. Among authors: errington rd. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):109-15. doi: 10.1016/j.ijrobp.2005.01.050. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111578
Recurrence of iris melanoma after proton beam therapy.
Sandinha MT, Kacperek A, Errington RD, Coupland SE, Damato B. Sandinha MT, et al. Among authors: errington rd. Br J Ophthalmol. 2014 Apr;98(4):484-7. doi: 10.1136/bjophthalmol-2013-303321. Epub 2014 Jan 10. Br J Ophthalmol. 2014. PMID: 24414401
44 results